Skip to main content
logo
S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea flag South Korea · Delayed Price · Currency is KRW
19,790
+790 (4.16%)
At close: Aug 20, 2026

S.Biomedics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
245,102453,470203,202130,376--
Market Cap Growth
2.82%123.16%55.86%---
Enterprise Value
255,617456,739206,789133,226--
Last Close Price
19790.0037950.0017300.0011500.00--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
14.8727.4014.809.95--
PB Ratio
14.6627.1111.1010.55--
P/TBV Ratio
31.6454.3117.7418.92--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
15.5127.6015.0610.16--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.790.730.770.9713.331.78
Net Debt / Equity Ratio
0.12-0.15-0.530.116.16-1.58
Net Debt / EBITDA Ratio
-0.270.392.63-0.30-2.851.91
Net Debt / FCF Ratio
-0.170.292.00-0.17-0.511.61
Asset Turnover
0.400.390.360.470.570.50
Inventory Turnover
3.974.262.993.335.146.18
Quick Ratio
1.531.332.201.670.753.19
Current Ratio
1.871.612.492.050.953.44
Return on Equity (ROE)
-41.23%-40.30%-37.96%-138.29%-195.41%-121.47%
Return on Assets (ROA)
-14.73%-12.15%-8.89%-13.30%-11.13%-16.13%
Return on Capital Employed (ROCE)
-33.30%-28.90%-16.60%-24.70%-30.00%-34.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.35%-1.79%-3.29%-7.92%--
FCF Yield
-4.87%-1.89%-2.41%-6.13%--
Buyback Yield / Dilution
-3.64%-3.22%-5.22%-6.97%-0.67%-0.42%